Volitionrx (VNRX) Enterprise Value Growth (1y) (2012 - 2025)
Volitionrx (VNRX) Enterprise Value Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn |
| 10 | Volitionrx | 99,574.04 | -1.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 44.82% |
| Sep 30, 2025 | 76.89% |
| Jun 30, 2025 | 50.07% |
| Mar 31, 2025 | 69.86% |
| Dec 31, 2024 | 79.37% |
| Sep 30, 2024 | 43.61% |
| Jun 30, 2024 | 65.37% |
| Mar 31, 2024 | -19.99% |
| Dec 31, 2023 | -89.51% |
| Sep 30, 2023 | -608.37% |
| Jun 30, 2023 | -19.78% |
| Mar 31, 2023 | 55.10% |
| Dec 31, 2022 | 45.11% |
| Sep 30, 2022 | 92.84% |
| Jun 30, 2022 | 38.78% |
| Mar 31, 2022 | 28.22% |
| Dec 31, 2021 | -6.99% |
| Sep 30, 2021 | -9.43% |
| Jun 30, 2021 | -31.02% |
| Dec 31, 2020 | -14.61% |